Filing Details
- Accession Number:
- 0001596783-21-000105
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-23 18:35:41
- Reporting Period:
- 2019-12-19
- Accepted Time:
- 2021-08-23 18:35:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1596783 | Catalent Inc. | CTLT | Pharmaceutical Preparations (2834) | 208737688 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1792807 | J Michael Grippo | C/O Catalent, Inc. 14 Schoolhouse Road Somerset NJ 08873 | Svp, Strategy & Corp. Dev. | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2019-12-19 | 1,846 | $54.00 | 15,733 | No | 4 | S | Direct | |
Common Stock | Disposition | 2019-12-20 | 2,406 | $56.00 | 13,327 | No | 4 | S | Direct | |
Common Stock | Disposition | 2020-01-13 | 1,680 | $58.00 | 11,647 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. This transaction was not reflected by the reporting person on subsequent Form 4 reports filed on April 13, 2020, July 28, 2020, August 3, 2020, August 31, 2020, September 8, 2020, October 13, 2020, January 5, 2021, May 24, 2021, and July 28, 2021.
- Includes restricted stock units.